Article
Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation.
The pharmacogenomics journal - 1 Feb 2015
Takahashi M, Saito T, Ito M, Tsukada C, Katono Y, Hosono H, Maekawa M, Shimada M, Mano N, Oda A, Hirasawa N, Hiratsuka M
Abstract excerpt
Genetic variations in cytochrome P450 2C19 (CYP2C19) contribute to interindividual variability in the metabolism of therapeutic agents such as clopidogrel. Polymorphisms in CYP2C19 are associated with large interindividual variations in the therapeutic efficacy of clopidogrel. This study evaluated the in vitro oxidation of clopidogrel by 21 CYP2C19 variants harboring amino acid substitutions. These CYP2C19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
